These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11781832)

  • 1. PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites.
    Santilli G; Cervellera MN; Johnson TK; Lewis RE; Iacobelli S; Sala A
    Oncogene; 2001 Dec; 20(57):8167-74. PubMed ID: 11781832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
    Saville MK; Watson RJ
    Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
    Bessa M; Saville MK; Watson RJ
    Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of cyclin A/Cdk2 phosphorylation sites in B-Myb.
    Bartsch O; Horstmann S; Toprak K; Klempnauer KH; Ferrari S
    Eur J Biochem; 1999 Mar; 260(2):384-91. PubMed ID: 10095772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain.
    Petrovas C; Jeay S; Lewis RE; Sonenshein GE
    Oncogene; 2003 Apr; 22(13):2011-20. PubMed ID: 12673206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of E2F-1 by cyclin A-cdk2.
    Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
    Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation and activation of B-Myb by cyclin A-Cdk2.
    Ziebold U; Bartsch O; Marais R; Ferrari S; Klempnauer KH
    Curr Biol; 1997 Apr; 7(4):253-60. PubMed ID: 9094315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin-dependent kinases regulate the antiproliferative function of Smads.
    Matsuura I; Denissova NG; Wang G; He D; Long J; Liu F
    Nature; 2004 Jul; 430(6996):226-31. PubMed ID: 15241418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT.
    Li X; McDonnell DP
    Mol Cell Biol; 2002 Jun; 22(11):3663-73. PubMed ID: 11997503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
    Joaquin M; Watson RJ
    J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation.
    Lane S; Farlie P; Watson R
    Oncogene; 1997 May; 14(20):2445-53. PubMed ID: 9188859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F1, B-myb and selective members of cyclin/cdk subunits are targets for protein kinase C-mediated bimodal growth regulation in vascular endothelial cells.
    Zhou W; Takuwa N; Kumada M; Takuwa Y
    Biochem Biophys Res Commun; 1994 Feb; 199(1):191-8. PubMed ID: 8123011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
    Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest.
    Strobeck MW; Fribourg AF; Puga A; Knudsen ES
    Oncogene; 2000 Apr; 19(15):1857-67. PubMed ID: 10773875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.
    Petersen BO; Lukas J; Sørensen CS; Bartek J; Helin K
    EMBO J; 1999 Jan; 18(2):396-410. PubMed ID: 9889196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J; Ammanamanchi S; Ko TC; Brattain MG
    Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines.
    Crowe DL; Shuler CF
    Cell Growth Differ; 1998 Aug; 9(8):619-27. PubMed ID: 9716179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.